Reactivación de la hepatitis B después de la lamivudina.

Cardiovascular risk profiles in patients with primary sclerosing cholangitis.

European journal of gastroenterology & hepatology·2026

Time-trends in disease characteristics and comorbidities in patients with chronic hepatitis B in the period 1980-2020.

European journal of internal medicine·2022

Hepatitis E infection with a benign course during vedolizumab treatment for Crohn's disease: A case report.

Clinics and research in hepatology and gastroenterology·2022

Fendrix® compared to Engerix® in HIV-infected patients nonresponding to initial- and re-vaccination schedule.

The Netherlands journal of medicine·2020

Conservative treatment versus elective repair of umbilical hernia in patients with liver cirrhosis and ascites: results of a randomized controlled trial (CRUCIAL trial).

Langenbeck's archives of surgery·2020

Fulminant Liver Failure due to Hepatitis B Reactivation During Treatment With Tocilizumab.

ACG case reports journal·2020

1-month versus 12-month dual antithrombotic therapy after percutaneous coronary intervention in patients with atrial fibrillation (OPTIMA-AF): a multicentre, open-label, hybrid non-inferiority and superiority, randomised, controlled trial.

Lancet (London, England)·2026

Multidomain lifestyle intervention for the prevention of cognitive decline in at-risk older adults in Latin America (LatAm-FINGERS): a single-blind, multicentre, randomised controlled trial.

Lancet (London, England)·2026

Advancing the relevance of clinical trials for older patients.

Lancet (London, England)·2026

Temocillin versus carbapenems for bacteraemia due to third-generation cephalosporin-resistant Enterobacterales in Spain (ASTARTÉ): a multicentre, phase 3, open-label, non-inferiority, randomised clinical trial.

Lancet (London, England)·2026

Fixed-duration pirtobrutinib plus venetoclax-rituximab versus venetoclax-rituximab for patients with previously treated chronic lymphocytic leukaemia or small lymphocytic lymphoma (BRUIN CLL-322): an open-label, multicentre, randomised, controlled, phase 3 trial.

Lancet (London, England)·2026

Children in all policies: lessons from a global collaboration to promote the health and wellbeing of children and future generations.

Lancet (London, England)·2026

Laser-based assessment of nanoparticle effects on RBC aggregation: an in vitro study.

Biomedical optics express·2026

Thrombotic microangiopathy following CAR T-cell therapy: a case series from the EBMT Complications Working Party.

Haematologica·2026

Biodistribution of tumor-targeted MXene-antibody conjugates.

Biomaterials science·2026

Metrics Used for the Evaluation of Chatbots Providing Cancer Genetic Risk Assessment and Education: Systematic Review.

JMIR AI·2026

Snare-assisted bailout of an embolized Evolut FX transcatheter aortic valve replacement prosthesis using a valve-through-valve balloon-expandable implantation.

Proceedings (Baylor University. Medical Center)·2026

Prophylactic and post-exposure efficacy of a Pichinde virus vector-based tuberculosis vaccine.

Frontiers in immunology·2026

Videos de Experimentos Relacionados

Reactivación de la hepatitis B después de la lamivudina.

Videos de Conceptos Relacionados

Cardiovascular risk profiles in patients with primary sclerosing cholangitis.

Time-trends in disease characteristics and comorbidities in patients with chronic hepatitis B in the period 1980-2020.

Hepatitis E infection with a benign course during vedolizumab treatment for Crohn's disease: A case report.

Fendrix® compared to Engerix® in HIV-infected patients nonresponding to initial- and re-vaccination schedule.

Conservative treatment versus elective repair of umbilical hernia in patients with liver cirrhosis and ascites: results of a randomized controlled trial (CRUCIAL trial).

Fulminant Liver Failure due to Hepatitis B Reactivation During Treatment With Tocilizumab.

1-month versus 12-month dual antithrombotic therapy after percutaneous coronary intervention in patients with atrial fibrillation (OPTIMA-AF): a multicentre, open-label, hybrid non-inferiority and superiority, randomised, controlled trial.

Multidomain lifestyle intervention for the prevention of cognitive decline in at-risk older adults in Latin America (LatAm-FINGERS): a single-blind, multicentre, randomised controlled trial.

Advancing the relevance of clinical trials for older patients.

Temocillin versus carbapenems for bacteraemia due to third-generation cephalosporin-resistant Enterobacterales in Spain (ASTARTÉ): a multicentre, phase 3, open-label, non-inferiority, randomised clinical trial.

Fixed-duration pirtobrutinib plus venetoclax-rituximab versus venetoclax-rituximab for patients with previously treated chronic lymphocytic leukaemia or small lymphocytic lymphoma (BRUIN CLL-322): an open-label, multicentre, randomised, controlled, phase 3 trial.

Children in all policies: lessons from a global collaboration to promote the health and wellbeing of children and future generations.

Laser-based assessment of nanoparticle effects on RBC aggregation: an in vitro study.

Thrombotic microangiopathy following CAR T-cell therapy: a case series from the EBMT Complications Working Party.

Biodistribution of tumor-targeted MXene-antibody conjugates.

Metrics Used for the Evaluation of Chatbots Providing Cancer Genetic Risk Assessment and Education: Systematic Review.

Snare-assisted bailout of an embolized Evolut FX transcatheter aortic valve replacement prosthesis using a valve-through-valve balloon-expandable implantation.

Prophylactic and post-exposure efficacy of a Pichinde virus vector-based tuberculosis vaccine.

Videos de Experimentos Relacionados

Reactivación de la hepatitis B después de la lamivudina.

Videos de Conceptos Relacionados

Artículos Relacionados